| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 07/24/2008 | WO2008087529A1 Nicotinic acetylcholine receptor modulators |
| 07/24/2008 | US20080176872 Chemical Compounds |
| 07/24/2008 | US20080176858 Selective antagonists of a2a adenosine receptors |
| 07/24/2008 | US20080176813 Carbocyclic nucleosides and process for obtaining such |
| 07/24/2008 | CA2712073A1 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use |
| 07/24/2008 | CA2675676A1 Nicotinic acetylcholine receptor modulators |
| 07/23/2008 | EP1947092A1 Nucleic acid base having perfluoroalkyl group and method for producing the same |
| 07/23/2008 | EP1946108A2 High quantum yield acridinium compounds and their uses in improving assay sensitivity |
| 07/23/2008 | EP1490367B1 Imidazopyridine derivatives as kinase inhibitors |
| 07/23/2008 | CN101228162A 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators |
| 07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |
| 07/17/2008 | WO2008007392A3 Process for the preparation of tenofovir |
| 07/17/2008 | US20080171049 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant; kits |
| 07/16/2008 | EP1943251A2 A1 adenosine receptor agonists |
| 07/16/2008 | CN101220070A Inosine derivative and process for producing the same |
| 07/16/2008 | CN101220032A Novel method for producing theobromine with 3_methylxanthine disodium salt methylating |
| 07/16/2008 | CN101220031A Acyclic purine nucleosides derivant and method of preparing the same |
| 07/16/2008 | CN100402545C Methods and compositions for treating hepatitis c virus |
| 07/15/2008 | CA2339250C Synthesis of acyclic nucleoside derivatives |
| 07/15/2008 | CA2144473C Pna synthesis using a base-labile amino protecting group |
| 07/10/2008 | US20080167325 Preparation of a valacyclovir composition that does not include wet granulation, e.g., dry granulation and compressing a powder blend to form tablets |
| 07/09/2008 | EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 07/09/2008 | EP1940843A2 Unsaturated heterocyclic derivatives |
| 07/09/2008 | EP1534289B1 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 07/09/2008 | CN101215287A Method for synthesizing guanine from urea |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/03/2008 | WO2008080005A1 Food products having caffeine incorporated therein |
| 07/03/2008 | WO2008077557A1 8-ethinylxanthine derivatives as selective a2a receptor antagonists |
| 07/03/2008 | US20080161327 Substituted 9-Alkyladenines and the Use Thereof |
| 07/03/2008 | US20080161326 Novel Sulfone Amide Amide Derivatives |
| 07/03/2008 | CA2672692A1 8-ethinylxanthine derivatives as selective a2a receptor antagonists |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1939202A1 Novel adenine compound |
| 07/02/2008 | EP1939201A1 Novel adenine compound |
| 07/02/2008 | EP1939200A1 Novel adenine compound |
| 07/02/2008 | EP1939199A1 Novel adenine compound |
| 07/02/2008 | EP1939198A1 Novel adenine compound |
| 07/02/2008 | EP1939197A1 8-ethinylxanthine derivatives as selective A2A receptor antagonists |
| 07/02/2008 | EP1939196A1 Process for the preparation of abacavir |
| 07/02/2008 | CN101210015A Method for preparing hepatitis B therapeutic medicament entecavir |
| 07/02/2008 | CN100398648C Probe foranalysis of nucleic acids |
| 07/02/2008 | CN100398542C Substituted 1,2,3- triazolepyridine compound with HIV-resistant activity, preparation method and uses |
| 07/01/2008 | US7393855 Treating human herpes virus, human immunodeficiency virus, and hepatitis B virus; optionally administered with other antiviral agents; (E)-9-{[2,2-bis-(hydroxymethyl)cyclopropylidene]methyl}adenine |
| 06/26/2008 | WO2008075110A1 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety |
| 06/26/2008 | WO2008075109A1 Substituted piperidines having protein kinase inhibiting activity |
| 06/26/2008 | WO2008075064A1 Piperidine derivatives for the treatment of obesity |
| 06/26/2008 | WO2008075007A1 Morpholino-substituted bicycloheteroaryl compounds and their use as anti cancer agents |
| 06/26/2008 | WO2008074874A1 Process for the preparation of abacavir |
| 06/26/2008 | WO2008047201A3 Solid dispersion comprising a poorly water soluble drug |
| 06/26/2008 | US20080154038 Simple, industrial scale; quaternary ammonium salt catalytic condensation of halogenated purine derivative with such as 2-acetoxymethyl-4-hydroxybutyl acetate in aprotic organic solvent containing inorganic base followed by hydrogenation; purity |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153856 3-Ethyl-1-propyl-8-{1-[(3-trifluoromethylphenyl)methyl]pyrazol-4-yl}-1,3,7-trihydropurine-2,6-dione; antiasthmatic and antidiarrhea agents |
| 06/26/2008 | US20080152702 Improved blood circulation lifetime of drug-carrying liposomes having a surface coating of releasable hydrophilic polymer covalently and reversibly linked to an phospholipid or polypeptide through a dithiobenzyl linkage |
| 06/26/2008 | CA2672841A1 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety |
| 06/26/2008 | CA2670432A1 Process for the preparation of abacavir |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/19/2008 | WO2008072074A1 An improved process for the preparation of purine derivative |
| 06/19/2008 | WO2008071976A1 8-oxoadenine derivatives as immuno-modulators |
| 06/19/2008 | US20080146590 P38 map kinase inhibitors and methods for using the same |
| 06/18/2008 | EP1932918A1 Method for the production of cladribine |
| 06/18/2008 | EP1931352A2 Tlr agonists |
| 06/18/2008 | CN101203519A 2-amido-6-amino-8-oxopurine derivatives as ToII-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c |
| 06/18/2008 | CN101200467A New compound generated by streptomycete and preparation method thereof |
| 06/18/2008 | CN100395245C Microcrystal |
| 06/17/2008 | US7388002 Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
| 06/12/2008 | US20080139585 phenyl-, pyridyl-, pyrimidyl- and purine- derivatives; anticarcinogenic agent; solid tumor: breast, colorectal, lung, prostate, and ovarian |
| 06/12/2008 | US20080139583 Phosphodiesterase 4 inhibitors |
| 06/12/2008 | US20080139566 4-Benzyloxymethyl-2-hydroxymethyl-2-(tetrazol-2-yl)oxetane; DNA and RNA nucleoside polymerase inhibitor; viral, fungal, bacterial, protozoa infections; anticarcinogenic agent: breast cancer |
| 06/11/2008 | EP1930308A1 Pharmaceutical agents for the treatment of cerebral amyloidosis |
| 06/11/2008 | EP1928877A1 Purine derivatives for the treatment of viral or allergic diseases and cancers |
| 06/11/2008 | EP1928876A1 Purine derivatives having immuno-modulating properties |
| 06/11/2008 | EP1532150B1 Novel purine derivatives, production and use thereof as medicaments |
| 06/11/2008 | EP1492803B1 New analogs of nitrobenzylthioinosine |
| 06/11/2008 | CN101198608A Prodrugs of A2b adenosine receptor antagonists |
| 06/11/2008 | CN101198607A Phenylacetamides suitable as protein kinase inhibitors |
| 06/11/2008 | CN101195622A Method of producing famciclovir |
| 06/11/2008 | CN101195621A Process for producing acyclovir |
| 06/11/2008 | CN101195620A Entecavir kalium, preparation method and application thereof |
| 06/11/2008 | CN101195619A Novel method for fine purification of theobromine |
| 06/11/2008 | CN100393741C Compounds with anti-inflammatory activity |
| 06/10/2008 | US7384967 Aryl carbonyl derivatives as therapeutic agents |
| 06/10/2008 | CA2427338C Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 06/10/2008 | CA2210799C Valaciclovir hydrochloride in anhydrous crystalline form |
| 06/05/2008 | US20080132540 Such as trans-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-N-(1-benzyl-piperidin-4-yl)-3-phenyl-acrylamide; for treating/preventing anxiolytic disorders/depression, injured mammalian nerve tissue, conditions, neurological disorders, bone loss, substance related disorders, and obesity; neuropeptide y (NPY Y2) |
| 06/05/2008 | US20080132526 Purine Derivative |
| 06/05/2008 | US20080132525 isoforms DNMT1 and DNMT3b2; for example: 2-amino-4-(((2S,3S,4R,5R)-3,4-dihydroxy-5-(6-(phenethylamino)-9H-purin-9-yl)-tetrahydrofuran-2-yl)methylthio)butanoic acid |
| 06/05/2008 | US20080132484 Screening for a modulator of Polio Like Kinase, designing and identifying small molecule inhibitors using a homology model for PLK |
| 06/05/2008 | CA2668579A1 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 06/04/2008 | EP1927604A1 Functional monomers for molecular recognition and catalysis |
| 06/04/2008 | EP1926703A1 Novel carboxylic acid derivatives |
| 06/04/2008 | EP1492791B1 Crystal and solvate of 2-amino-6-benzyloxypurine and production methods thereof |
| 06/04/2008 | CN101190912A Antiviral compound and preparation method thereof |
| 05/29/2008 | US20080125446 For example, 6-amino-2-(chloro or fluoro)-8-(arylthio(oxo))-9H-purines; complex with Heat Shock Protein 90 (HSP 90); proliferative disorders such as breast cancer |
| 05/29/2008 | US20080125426 7-(4-Chlorophenyl)-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; reversible inhibitors of cysteine proteases S, K, F, L, B; diseases associated with Cathepsin S; antiinflammatory agent, autoimmune diseases; asthma, rheumatoid arthritis, multiple sclerosis, Alzheimer's and Crohn's disease |
| 05/29/2008 | CA2650227A1 Substituted pyrazolopyrimidines |
| 05/28/2008 | CN100390178C Polycycloalkylpurines as adenosine receptor antagonists |
| 05/27/2008 | US7378433 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 05/27/2008 | US7378412 Pharmaceutical compounds |
| 05/22/2008 | US20080119496 7-Substituted Purine Derivatives for Immunosuppression |
| 05/22/2008 | US20080119495 Phosphodiesterase 4 inhibitors |